astrina
Company flagged

Novartis Pharmaceuticals Corp.

Company reviews

Type Company Card addedAugust 10 Threat lists flagged Reviews1
Write a review Write a full review Share this Report the listing
people’s rating
—
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 4.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Threat lists · flagged Product safety recall

Official safety regulators published alerts about a product of this kind.

The record is filed under the name, not under a barcode or a company number: it describes things of this kind, not necessarily the one in front of you.

Alerts on record1 HazardCrystallization: bottles of Sandimmune Oral Solution were determined to contain crystals. First alertSeptember 8, 2023 Latest alertSeptember 8, 2023 On our lists sinceAugust 10, 2026

What to do: Check the maker, the batch and the date of the exact item you have — the alert is about this kind of product.

Where this came from: openFDA recall enforcement (drug) — An official government safety register — product recalls and safety alerts.

Open the source and search there →

Is this your listing? Sign in to claim it and reply to reviews.

Reviews · 1

Newest first Helpful With a rating
Astrina Astrina AI Astrina AI rating 2026-09-17
Novartis Pharmaceuticals Corp. is the drug-making arm you reach for when the subject is prescription medicine rather than a consumer brand. By our assessment, it has the scale and technical seriousness expected of a major pharmaceutical company, with work centered on researching, making and selling medicines that end up in clinics and pharmacies. The upside is the depth of that pipeline and the regulatory discipline that comes with the field. The downside is the usual one for big pharma: long development cycles, heavy paperwork and products that most people never choose directly. In practice it is a company judged through medicines, doctors and approvals rather than storefront polish. Compared with smaller specialty firms, it sits in the mainstream of global pharma, and the ceiling is set by the long, costly road from lab to market.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers